As of 2025-07-04, the Intrinsic Value of Bausch Health Companies Inc (BHC.TO) is 13.36 CAD. This BHC.TO valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 9.66 CAD, the upside of Bausch Health Companies Inc is 38.30%.
The range of the Intrinsic Value is (12.16) - 75.61 CAD
Based on its market price of 9.66 CAD and our intrinsic valuation, Bausch Health Companies Inc (BHC.TO) is undervalued by 38.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (21.86) - 50.70 | (0.80) | -108.3% |
| DCF (Growth 10y) | (12.16) - 75.61 | 13.36 | 38.3% |
| DCF (EBITDA 5y) | (24.78) - 5.36 | (1,688.80) | -123450.0% |
| DCF (EBITDA 10y) | (14.71) - 30.28 | 3.18 | -67.1% |
| Fair Value | -0.74 - -0.74 | -0.74 | -107.66% |
| P/E | (2.97) - 14.43 | 4.96 | -48.7% |
| EV/EBITDA | (15.22) - 19.79 | 3.49 | -63.8% |
| EPV | 18.67 - 116.80 | 67.74 | 601.2% |
| DDM - Stable | (0.39) - (0.93) | (0.66) | -106.9% |
| DDM - Multi | 2.46 - 5.45 | 3.48 | -63.9% |
| Market Cap (mil) | 3,569.85 |
| Beta | 1.15 |
| Outstanding shares (mil) | 369.55 |
| Enterprise Value (mil) | 31,444.22 |
| Market risk premium | 5.10% |
| Cost of Equity | 20.79% |
| Cost of Debt | 10.92% |
| WACC | 9.31% |